Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera

Annals of the New York Academy of Sciences

Volumn 1132, Issue , 2008, Pages 291-299

  Tzartos, Socrates J ^a,b   Bitzopoulou, Kalliopi ^a,b   Gavra, Ira ^a,b   Kordas, Grigoris ^b   Jacobson, Leslie ^a,c   Kostelidou, Kalliopi ^a   Lagoumintzis, George ^b   Lazos, Orestis ^a   Poulas, Kostantinos ^b   Sideris, Sotiris ^b   Sotiriadis, Alexandros ^a   Trakas, Nikos ^a   Zisimopoulou, Paraskevi ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Acetylcholine receptor; Autoantibodies; Autoimmune diseases; Extracellular domain; Myasthenia gravis; Specific immunoadsorption; Therapy

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; CELL CULTURE; CONFERENCE PAPER; ESCHERICHIA COLI; GEL FILTRATION; IMMUNOADSORBENT; MOUSE; MYASTHENIA GRAVIS; NONHUMAN; PICHIA PASTORIS; PLASMAPHERESIS; PROTEIN EXPRESSION; RABBIT;

ORYCTOLAGUS CUNICULUS; PICHIA PASTORIS; RATTUS;

EID: 45249089477     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1405.017     Document Type: Conference Paper

References (18)

1. Vincent, A. 2002. Unravelling the pathogenesis of myasthenia gravis. Nat. Rev. Immunol. 2 : 797 804.
2. Hoch, W., J. McConville, S. Helms, et al. 2001. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7 : 365 368.
3. Karlin, A. 2002. Emerging structure of the nicotinic acetylcholine receptors. Nat. Rev. Neurosci. 3 : 102 114.
4. Tzartos, S.J., T. Barkas, M.T. Cung, et al. 1998. Anatomy of the antigenic structure of a large membrane autoantigen, the muscle-type nicotinic acetylcholine receptor. Immunol. Rev. 163 : 89 120.
5. Newsom-Davis, J., S.G. Wilson, A. Vincent, et al. 1979. Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet 1 : 464.
6. Lindstrom, J.M., A.G. Engel, M.E. Seybold, et al. 1976. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies. J. Exp. Med. 144 : 739 753.
7. Lindstrom, J.M., M.E. Seybold, V.A. Lennon, et al. 1976. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 26 : 1054 1059.
8. Fostieri, E., K. Kostelidou, K. Poulas, et al. 2006. Recent advances in the understanding and therapy of myasthenia gravis. Future Neurol. 1 : 799 801.
9. Sieb, J.P. 2005. Myasthenia gravis: emerging new therapy options. Curr. Opin. Pharmacol. 5 : 303 307.
10. Pinching, A.J. & D.K. Peters. 1976. Remission of myasthenia gravis following plasma-exchange. Lancet 2 : 1373 1376.
11. Batocchi, A.P., A. Evoli, C. Dischino, et al. 2000. Therapeutic apheresis in myasthenia gravis. Ther. Apher. 4 : 275 279.
12. Kuks, J.B. & D. Skallebaek. 1998. Plasmapheresis in myasthenia gravis: a survey. Transfus. Sci. 19 : 129 136.
13. Psaridi-Linardaki, L., A. Mamalaki, M. Remoundos, et al. 2002. Expression of soluble ligand- and antibody-binding extracellular domain of human muscle acetylcholine receptor alpha subunit in yeast Pichia pastoris. Role of glycosylation in alpha-bungarotoxin binding. J. Biol. Chem. 277 : 26980 26986.
14. Kostelidou, K., N. Trakas, M. Zouridakis, et al. 2006. Expression and characterization of soluble forms of the extracellular domains of the beta, gamma and epsilon subunits of the human muscle acetylcholine receptor. FEBS J. 273 : 3557 3568.
15. Psaridi-Linardaki, L., N. Trakas, A. Mamalaki, et al. 2005. Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy. J. Neuroimmunol. 159 : 183 191.
16. Kostelidou, K., N. Trakas & S.J. Tzartos. 2007. Extracellular domains of the β, γ and ε subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency. J. Neuroimmunol. 190 : 44 52.
17. Tsouloufis, T., A. Mamalaki, M. Remoundos, et al. 2000. Reconstitution of conformationally-dependent epitopes on the N-terminal extracellular domain of the human muscle acetylcholine receptor α-subunit expressed in E. coli. Implications for Myasthenia Gravis therapeutic approaches. Int. Immunol. 12 : 1255 1265.
18. Sideris, S., G. Lagoumintzis, G. Kordas, et al. 2007. Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: receptor loss in cell culture. J. Neuroimmunol. 189 : 111 117.